Acumen Pharmaceuticals (ABOS)
(Delayed Data from NSDQ)
$2.39 USD
-0.11 (-4.40%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $2.40 +0.01 (0.42%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.36 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | -21.43% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.32 |
Next Year | -1.40 |
EPS (TTM) | -1.12 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.36 | -0.40 | -1.32 | -1.40 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | -0.25 | -0.25 | -1.01 | -1.11 |
High Estimate | -0.25 | -0.25 | -1.01 | -1.11 |
Low Estimate | -0.46 | -0.54 | -1.59 | -1.86 |
Year ago EPS | -0.24 | -0.29 | -1.08 | -1.32 |
Year over Year Growth Est. | -50.00% | -37.93% | -22.22% | -6.31% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.36 | -0.40 | -1.32 | -1.40 |
7 Days Ago | -0.36 | -0.40 | -1.32 | -1.40 |
30 Days Ago | -0.36 | -0.40 | -1.32 | -1.40 |
60 Days Ago | -0.31 | -0.32 | -1.13 | -1.37 |
90 Days Ago | -0.31 | -0.32 | -1.13 | -1.37 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.40 | -1.32 | -1.40 |
Zacks Consensus Estimate | -0.36 | -0.40 | -1.32 | -1.40 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.25 | -0.29 | -0.24 | NA |
Estimate | -0.28 | -0.23 | -0.29 | -0.31 | NA |
Difference | -0.06 | -0.02 | 0.00 | 0.07 | 0.00 |
Surprise | -21.43% | -8.70% | 0.00% | 22.58% | -1.89% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more